About us

Our goal is to increase the level of Clinical Trial investments in Africa by increasing the visibility of African clinical trialists and research centers as well as making transparent and accessible individual country regulatory and ethics procedures to inform decision making by sponsors. The Clinical Trials Community provides a platform for constant engagement among key stakeholders to increase efficiency and promote steady collaborations

Our Goals

Increase visibility

African Clinical Trialists and Sites by indicating the geographical location and corresponding disease burden

Remove duplication

Reduce unnecessary duplication of efforts by providing access to current site feasibility data

Improving predictability

Providing access to regulatory and ethics requirements across countries and an online platform for sponsor engagement

Reducing bias

Funding across countries and disease areas by highlighting gaps and promoting synergy across strategic funders

Our History

2017
  • Prof Tom Kariuki presented the CTC concept at the World Economic Forum, Davos, Switzerland meeting
2018
  • Dalberg Report on Inventory of clinical trial sites in Africa presented to key stakeholders
  • Dalberg Report presented at Grand Challenges Annual Meeting in Berlin
2019
  • Prof Tom Kariuki & Prof Colin Pillai announce CTC platform at multiple African forums (DELTAS Africa Annual Meeting, Global Emerging Pathogens Treatment Consortium (GET) & Health in Africa (H3Africa) consortium meeting
  • Initial conceptual design of CTC platform (wire-frames) presented at Grand Challenges meeting in Addis Adaba
2020
  • nuvoteQ appointed as Technology Partner to help build the CTC platform
  • Draft version of CTC platform used for Africa CDC presentation to help identify potential COVID-19 vaccine sites
  • Version 1.0 of CTC Platform launched at Grand Challenges Meeting (Virtual)
2021
  • A strategic decision was taken to move ownership of CTC platform to nuvoteQ (with close collaboration with Science for Africa Foundation) as the interim host with a commitment of identifying the best suited permanent host.
  • First peer-reviewed publication mentioning the CTC, platform (read more)
  • Strategic decision taken to move ownership of CTC platform to nuvoteQ
2022
  • 2000th research centre loaded onto the CTC Platform
  • Work started on new CTC features including digital feasibility requests, jobs portal and artificial neural network used for automated data cleaning received from public sources
  • Planned release of Version 2.0 of CTC platform in October 2022 featuring a brand new look and feel
2023
  • The Steering committee approved the transfer of ownership of the platform to a pan-African organisation with the mandate of leadership for research and development on the continent – timing for this announcement will be Q1 2024.
  • Planned release of Version 2.1 of the CTC platform in February 2023 which will include new modules (Digital Feasibilities & Jobs Portal, Interactive Communication Module, Service Provider Module, User Discussion Forum)

Contribution Partners

http://www.scienceforafrica.foundation/
https://www.janssen.com/
https://www.fondation-merieux.org/
https://www.medicinesdevelopment.com/
https://www.gatesfoundation.org/

Technology & Data Partners

https://nuvoteq.io
https://scigenix.ai

Funding Partners

https://ec.europa.eu/
https://www.edctp.org/

Acknowledgements and data sources

We are grateful that the following resources have provided open access to their data.
https://www.nih.gov/
https://clinicaltrials.gov/
http://www.healthdata.org/
https://cepi.net/
https://tghn.org/
https://pmxafrica.org/
https://www.fhiclinical.com/
https://www.nepad.org/
https://tghn.org/